An international comparison of pulmonary rehabilitation: a systematic review

Laura Desveaux1, Tania Janaudis-Ferreira, Roger Goldstein

  • 11Graduate Department of Rehabilitation Science, Faculty of Medicine, University of Toronto , Toronto, Ontario , Canada.

COPD
|July 2, 2014
PubMed

Insights

Pulmonary rehabilitation (PR) programs are similar globally, but access is limited, with only 1.2% of individuals with COPD enrolled. Increasing PR capacity could improve quality of life and reduce healthcare costs.

Area of Science:

  • Pulmonary Medicine
  • Rehabilitation Science
  • Health Services Research

Background:

  • Pulmonary rehabilitation (PR) is evidence-based but perceived as limited in provision.
  • Disparities in PR delivery lead to increased healthcare costs and underserved populations.
  • Understanding international PR structure and availability is crucial.

Purpose of the Study:

  • To systematically review and characterize the international provision of PR.
  • To compare the structure and delivery of PR programs across different countries.
  • To assess PR availability in relation to geographical prevalence.

Main Methods:

  • Systematic review of electronic databases from inception to September 2013.
  • Keywords: "pulmonary rehabilitation" and "survey."
  • Independent review and quality assessment by two authors with data double-checking.

Main Results:

  • Most PR programs (55-99%) are outpatient-based, except in Ireland (65% community-based).
  • Exercise (77-100%) and education (74-100%) are core components; physical therapists are common team members (49-100%).
  • Functional walk tests are frequent outcome measures, with variations across countries; PR services reach only ≤1.2% of individuals with COPD.

Conclusions:

  • PR program components are globally consistent, but outcome measures vary.
  • Community-based PR is emerging, though outpatient settings dominate.
  • Limited PR access (≤1.2% of COPD patients) highlights a need for increased capacity to enhance quality of life and reduce healthcare utilization.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...